[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
July 14, 1999

Experts Debate Drugs for Healthy Women With Breast Cancer Risk

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;282(2):117-118. doi:10.1001/jama.282.2.117

Atlanta—For some time, anxiety and "watchful waiting" have been the usual prescription for women with an elevated risk of developing breast cancer. Now, however, a working group convened by the nation's largest group of cancer specialists cautiously suggests that physicians consider offering a risk-reduction measure—the drug tamoxifen—to healthy women age 35 and older who have an increased risk of developing the disease.

But this advice, presented in a new report unveiled at the annual meeting of the American Society of Clinical Oncology (ASCO), fell far short of a ringing endorsement of prescribing tamoxifen for healthy women.

First Page Preview View Large
First page PDF preview
First page PDF preview
×